Shao Jing Tong
Director of Finance/CFO chez REMEGEN CO., LTD.
Profil
Actuellement, Shaojing Tong occupe le poste de directeur financier chez InnoCare Pharma Ltd. M. Tong est également membre du conseil d'administration de YishengBio Co, Ltd. Auparavant, M. Tong a occupé les postes de directeur de la recherche mondiale chez Bank of America Merrill Lynch (New York), d'analyste de recherche chez Mehta Partners LLC, de directeur exécutif de la recherche bancaire d'investissement chez UBS (China) Ltd, d'analyste de recherche chez Merrill Lynch Far East Ltd et d'analyste chez UBS Securities (Asia) Ltd. Shaojing Tong est titulaire d'un MBA de l'université de New York, d'un diplôme d'études supérieures de l'université de Pittsburgh et d'un diplôme de premier cycle de l'université des sciences et technologies de Chine.
Postes actifs de Shao Jing Tong
| Sociétés | Poste | Début |
|---|---|---|
| REMEGEN CO., LTD. | Director of Finance/CFO | 28/09/2023 |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Director/Board Member | - |
Anciens postes connus de Shao Jing Tong
| Sociétés | Poste | Fin |
|---|---|---|
| YS BIOPHARMA CO., LTD. | Director/Board Member | 29/02/2024 |
| INNOCARE PHARMA LIMITED | Director of Finance/CFO | 31/12/2022 |
UBS Securities (Asia) Ltd.
 UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Analyst-Equity | 31/05/2019 |
UBS (China) Ltd.
 UBS (China) Ltd. Major BanksFinance Part of UBS Group AG, UBS (China) Ltd. provides retail and commercial banking services. The private company is based in Beijing, China. | Corporate Officer/Principal | 01/05/2019 |
| Bank of America Merrill Lynch (New York) | Corporate Officer/Principal | 01/05/2013 |
Formation de Shao Jing Tong
| University of Pittsburgh | Graduate Degree |
| New York University | Masters Business Admin |
| University of Science & Technology of China | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INNOCARE PHARMA LIMITED | Health Technology |
| REMEGEN CO., LTD. | Health Technology |
| YS BIOPHARMA CO., LTD. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Mehta Partners LLC
 Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | Finance |
Merrill Lynch Far East Ltd.
 Merrill Lynch Far East Ltd. Investment Banks/BrokersFinance Merrill Lynch Far East Ltd. is the stockbroking subsidiary of Merrill Lynch HK Services Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. Headquartered in Hong Kong, the firm was founded in 2003 and offers a broad range of brokerage services to institutional investors. | Finance |
UBS Securities (Asia) Ltd.
UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Finance |
| Bank of America Merrill Lynch (New York) | |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Health Technology |
UBS (China) Ltd.
UBS (China) Ltd. Major BanksFinance Part of UBS Group AG, UBS (China) Ltd. provides retail and commercial banking services. The private company is based in Beijing, China. | Finance |
